Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206

NCT04009122 is registered in ClinicalTrials.gov with Igen BioLab SLU as lead sponsor.

NCT NCT04009122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04009122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206
Lead sponsor
Igen BioLab SLU
Phase
Not applicable
Overall status
Completed
Start date
June 11, 2019
Completion date
December 14, 2022
Enrollment
266 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer metastatic, quality of life of patients